Joshua Burke

机构：University of New Brunswick, Hofstra University

发表论文 50 篇 · 总被引 1222 次 · h-index 14

代表论文

• A Phase 3, 1-Year, Open-Label Trial of Valbenazine in Adults With Tardive Dyskinesia (2019 · Journal of Clinical Psychopharmacology · 被引 33)
• Efficacy of Valbenazine (NBI-98854) in Treating Subjects with Tardive Dyskinesia and Schizophrenia or Schizoaffective Disorder (2025 · Psychopharmacology Bulletin · 被引 23)
• Long-Term Safety and Tolerability of Valbenazine (NBI-98854) in Subjects with Tardive Dyskinesia and a Diagnosis of Schizophrenia or Mood Disorder (2025 · Psychopharmacology Bulletin · 被引 23)
• The effects of valbenazine on tardive dyskinesia in patients with a primary mood disorder (2018 · Journal of Affective Disorders · 被引 14)
• Efficacy of Valbenazine (NBI-98854) in Treating Subjects with Tardive Dyskinesia and Mood Disorder (2025 · Psychopharmacology Bulletin · 被引 13)
• The effects of valbenazine on tardive dyskinesia in older and younger patients (2019 · International Journal of Geriatric Psychiatry · 被引 10)